Peer Review History

Original SubmissionJune 16, 2023
Decision Letter - Virginia E. Pitzer, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Dear Dr Voliotis,

Thank you very much for submitting your manuscript "HormoneBayes: a novel Bayesian framework for the analysis of pulsatile hormone dynamics" (PCOMPBIOL-D-23-00942) for consideration at PLOS Computational Biology. As with all papers, your manuscript was reviewed by members of the editorial board. Based on our initial assessment and discussion amongst the editors, we regret that we will not be pursuing this manuscript for publication at PLOS Computational Biology.

Unfortunately, we feel the tool presented in this manuscript seems to apply to data (dense time courses of lutinizing hormone from patients) that do not typically exist. Therefore the significance is quite limited.

We are sorry that we cannot be more positive on this occasion. We very much appreciate your wish to present your work in one of PLOS's Open Access publications. Thank you for your support, and we hope that you will consider PLOS Computational Biology for other submissions in the future.

Sincerely,

Virginia E. Pitzer, Sc.D.

Section Editor

PLOS Computational Biology

Virginia Pitzer

Section Editor

PLOS Computational Biology

Revision 1

Attachments
Attachment
Submitted filename: apppeal_letter.pdf
Decision Letter - Marc R Birtwistle, Editor, Virginia E. Pitzer, Editor

Dear Dr Voliotis,

Thank you very much for submitting your manuscript "HormoneBayes: a novel Bayesian framework for the analysis of pulsatile hormone dynamics" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

The reviews noted major deficiencies in model validation/comparison to "gold standard", novelty, true utility for clinicians, and how a personalized analysis would be done. Moreover there seem to be errors in the code implementation noted. These deficiencies would need to be strongly addressed in the revision, in addition to the other major points raised by reviewers.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. We may also try to recruit a third reviewer if necessary to reconcile any remaining points of ambiguity. 

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Marc R Birtwistle, PhD

Academic Editor

PLOS Computational Biology

Virginia Pitzer

Section Editor

PLOS Computational Biology

***********************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This paper describes the use of Bayesian modelling to provide an alternative to the standard deconvolutional methods used to model hormone pulsatility. When applied to the specific hormone LH, these models provide both a close fit to observed data and useful inferences about the underlying hypothalamus-pituitary modulation. The study demonstrates careful use of parsimonious modelling and high-quality human data, and has results suggesting a clear benefit when compared to the use of purely deconvolotional methods. The ability to compare and contrast pre- and post menopausal women is very interesting, as the literature contains conflicting results in this area.

Major comments:

Novelty is an issue. The users should explain how this work differs from PMID: 14601766 and PMID: 29287490 (the latter also providing open-access Baysian code for LH pulsatility).

The results would be improved by (a) an indication of goodness of fit to the data (maybe coefficient of determination added to the upper right subfigure in figure 1) and (b) an example of how a personalised analysis would be performed and used.

"there is a lack of user-friendly methods for computational analysis of the LH data available to clinicians" The current manuscript does not provide enough detail to demonstrate clinician user-friendliness of the distributed code.

Minor comments:

add chmod 755 hormoneBayes (or similar) to the user guide

settings_example.csv (in the user guide) is settings_example.txt (in the distribution)

I get the following error when using the data and settings given in the user guide (mypath is shorthand for my path to the directory containg the executable):

Exception in Tkinter callback

Traceback (most recent call last):

File "tkinter/__init__.py", line 1892, in __call__

File "pulsatile_GUI.py", line 340, in start_analysis

File "shutil.py", line 264, in copyfile

FileNotFoundError: [Errno 2] No such file or directory: '/mypath/data/data.csv'

"hormoneBayes allows the input of two LH profiling datasets, corresponding to control and perturbed conditions" How is this done? The interface allows only one dataset.

Reviewer #2: The paper by Voliotis, et al. reports the development of HormoneBayes, a Bayesian model to identify pulsatile hormone dynamics from clinical measurements. The paper would benefit from the following suggestions.

1. Details about the testing of the method are not provided. How was the model applied to the different patients data? Was it the same model or was it different (i.e. different priors) for each type?

2. Details about the gold standard model are not present? What was the method used? How does it differ from HormoneBayes? What are the advantages of HormoneBayes over the existing method – that is, why would someone want to use HormoneBayes and not just use the ‘gold standard’ method? Confidence for the measurement is mentioned as an advantage, but more discussion needs to be added to detail what the differences are and the advantages of HormoneBayes.

3. HormoneBayes seems to produce some false negatives and some false positive results relative to the gold standard methods. The implications of this are not discussed. How impactful would these be on patient care and/or diagnosis?

4. If possible the gold standard method should be run on the larger dataset and results compared with those of HormoneBayes since this would add to the information about how it performs relative to the standard methods.

5. The discussion is somewhat limited and should include a recap of the main advantages of HormoneBayes (see point 2), the implications for HormoneBayes – what will it allow that is not currently possible?, a discussion of the practical aspects of HormoneBayes – what is the path for making it to actual use in the clinic?

6. A description of the software is lacking. That is, what language was it written in, what requirements (libraries, etc.) does it have, how does the GUI work, what system(s) is it available on, how easy would it be for someone with limited computational experience to install and use?

7. The Github repository listed appears to have the code available, and the use of a Docker container is welcome, but the documentation is very limited and should be part of the README, not just a Word document. Also, is the software limited to Macintosh only? That seems to be indicated in the Word document.

8. The data described in the paper and on which the results are based does not appear to be available anywhere and should be made available in a suitable fashion (potentially as part of the Github repository) so that the results could be replicated.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: No: Code is available, but it appears that data from the paper is not.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tom Kelsey

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 2

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Marc R Birtwistle, Editor, Virginia E. Pitzer, Editor

Dear Dr Voliotis,

We are pleased to inform you that your manuscript 'HormoneBayes: a novel Bayesian framework for the analysis of pulsatile hormone dynamics' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Marc R Birtwistle, PhD

Academic Editor

PLOS Computational Biology

Virginia Pitzer

Section Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: My concerns at the R1 stage have been fully addressed in this version.

Reviewer #2: The authors have addressed all my comments and the manuscript is greatly improved.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tom Kelsey

Reviewer #2: No

Formally Accepted
Acceptance Letter - Marc R Birtwistle, Editor, Virginia E. Pitzer, Editor

PCOMPBIOL-D-23-00942R2

HormoneBayes: a novel Bayesian framework for the analysis of pulsatile hormone dynamics

Dear Dr Voliotis,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofia Freund

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .